{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:55:55Z","timestamp":1787003755897,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-92311-2","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T06:26:53Z","timestamp":1743661613000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Co-occurring illicit fentanyl use and psychiatric disorders in emergency department patients"],"prefix":"10.1038","volume":"15","author":[{"given":"Allie","family":"Downs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Shelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,1]]},"reference":[{"key":"92311_CR1","unstructured":"NIDA. August 21. Drug overdose deaths: facts and fig.\u00a0(2024). retrieved from https:\/\/nida.nih.gov\/research-topics\/trends-statistics\/overdose-death-rates on 2024, November 18."},{"key":"92311_CR2","unstructured":"Spencer, M. et al. Vital statistics rapid release \u2013 Centers for disease control and prevention. Accessed 28 Oct 2023, from (2023). https:\/\/www.cdc.gov\/nchs\/data\/vsrr\/vsrr030.pdf"},{"key":"92311_CR3","unstructured":"Centers for disease control and prevention. Fentanyl facts. accessed 4 Dec 2023, from (2023)., September 6 https:\/\/www.cdc.gov\/stopoverdose\/fentanyl\/index.html#:~:text=Fentanyl%20is%20a%20synthetic%20opioid,nonfatal%20overdoses%20in%20the%20U.S.&text=There%20are%20two%20types%20of,Both%20are%20considered%20synthetic%20opioids"},{"key":"92311_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.forsciint.2018.05.042","volume":"289","author":"K Kuczy\u0144ska","year":"2018","unstructured":"Kuczy\u0144ska, K., Grzonkowski, P., Kacprzak, \u0141. & Zawilska, J. B. Abuse of Fentanyl: an emerging problem to face. Forensic Sci. Int. 289, 207\u2013214. https:\/\/doi.org\/10.1016\/j.forsciint.2018.05.042 (2018).","journal-title":"Forensic Sci. Int."},{"key":"92311_CR5","unstructured":"National institutes on drug abuse. Fentanyl. accessed 15 Nov 2023, from (2021b). https:\/\/nida.nih.gov\/research-topics\/fentanyl"},{"issue":"2","key":"92311_CR6","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1001\/jamapsychiatry.2018.3126","volume":"76","author":"ND Volkow","year":"2019","unstructured":"Volkow, N. D., Jones, E. B., Einstein, E. B. & Wargo, E. M. Prevention and treatment of opioid misuse and addiction: A review. JAMA Psychiatry. 76 (2), 208\u2013216. https:\/\/doi.org\/10.1001\/jamapsychiatry.2018.3126 (2019).","journal-title":"JAMA Psychiatry"},{"key":"92311_CR7","unstructured":"U.S. Department of health and human services. (n.d.). When addiction and mental illness collide. National institutes of health. accessed 27. from Oct (2023). https:\/\/heal.nih.gov\/news\/stories\/collaborative-care"},{"key":"92311_CR8","unstructured":"Common comorbidities with substance use disorders research report. Bethesda (MD): National institutes on drug abuse (US); 2020 Apr. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK571451\/"},{"key":"92311_CR9","doi-asserted-by":"publisher","first-page":"108414","DOI":"10.1016\/j.drugalcdep.2020.108414","volume":"219","author":"MT Taylor","year":"2021","unstructured":"Taylor, M. T., Horton, D. B., Juliano, T., Olfson, M. & Gerhard, T. Outpatient prescribing of opioids to adults diagnosed with mental disorders in the united States. Drug Alcohol Depend. 219, 108414. https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108414 (2021).","journal-title":"Drug Alcohol Depend."},{"issue":"5","key":"92311_CR10","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3109\/10673229709030550","volume":"4","author":"EJ Khantzian","year":"1997","unstructured":"Khantzian, E. J. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv. Rev. Psychiatry. 4 (5), 231\u2013244. https:\/\/doi.org\/10.3109\/10673229709030550 (1997).","journal-title":"Harv. Rev. Psychiatry"},{"issue":"1\u20132","key":"92311_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.psychres.2007.10.009","volume":"165","author":"JV Bizzarri","year":"2009","unstructured":"Bizzarri, J. V. et al. Substance use in severe mental illness: self-medication and vulnerability factors. Psychiatry Res. 165 (1\u20132), 88\u201395. https:\/\/doi.org\/10.1016\/j.psychres.2007.10.009 (2009).","journal-title":"Psychiatry Res."},{"key":"92311_CR12","doi-asserted-by":"publisher","first-page":"109551","DOI":"10.1016\/j.drugalcdep.2022.109551","volume":"238","author":"T Santo Jr","year":"2022","unstructured":"Santo, T. Jr et al. Prevalence of mental disorders among people with opioid use disorder: A systematic review and meta-analysis. Drug Alcohol Depend. 238, 109551. https:\/\/doi.org\/10.1016\/j.drugalcdep.2022.109551 (2022).","journal-title":"Drug Alcohol Depend."},{"issue":"9","key":"92311_CR13","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/da.22771","volume":"35","author":"S Turner","year":"2018","unstructured":"Turner, S., Mota, N., Bolton, J. & Sareen, J. Self-medication with alcohol or drugs for mood and anxiety disorders: A narrative review of the epidemiological literature. Depress. Anxiety. 35 (9), 851\u2013860. https:\/\/doi.org\/10.1002\/da.22771 (2018).","journal-title":"Depress. Anxiety"},{"key":"92311_CR14","doi-asserted-by":"publisher","first-page":"108602","DOI":"10.1016\/j.drugalcdep.2021.108602","volume":"221","author":"PJ Freda","year":"2021","unstructured":"Freda, P. J., Moore, J. H. & Kranzler, H. R. The phenomics and genetics of addictive and affective comorbidity in opioid use disorder. Drug Alcohol Depend. 221, 108602. https:\/\/doi.org\/10.1016\/j.drugalcdep.2021.108602 (2021).","journal-title":"Drug Alcohol Depend."},{"key":"92311_CR15","unstructured":"U.S. Department of justice. heroin and opioid awareness. opioid facts. Accessed 4 Dec 2023, from (2022)., November 28 https:\/\/www.justice.gov\/opioidawareness\/opioid-facts#:~:text=The%20increase%20in%20drug%20overdose,cocaine%2C%20and%20other%20street%20drugs"},{"issue":"6","key":"92311_CR16","doi-asserted-by":"publisher","first-page":"e281","DOI":"10.1097\/ADM.0000000000000717","volume":"14","author":"LA Walter","year":"2020","unstructured":"Walter, L. A. & Li, L. Opioid use disorder in the emergency department amid COVID-19. J. Addict. Med. 14 (6), e281\u2013e283. https:\/\/doi.org\/10.1097\/ADM.0000000000000717 (2020).","journal-title":"J. Addict. Med."},{"issue":"2","key":"92311_CR17","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.annemergmed.2021.03.013","volume":"79","author":"WE Soares","year":"2022","unstructured":"Soares, W. E. 3 et al. Emergency department visits for nonfatal opioid overdose during the COVID-19 pandemic across six US health care systems. Ann. Emerg. Med. 79 (2), 158\u2013167. https:\/\/doi.org\/10.1016\/j.annemergmed.2021.03.013 (2022).","journal-title":"Ann. Emerg. Med."},{"issue":"5","key":"92311_CR18","doi-asserted-by":"publisher","first-page":"20m13241","DOI":"10.4088\/JCP.20m13241","volume":"81","author":"KM Theriault","year":"2020","unstructured":"Theriault, K. M., Rosenheck, R. A. & Rhee, T. G. Increasing emergency department visits for mental health conditions in the united States. J. Clin. Psychiatry. 81 (5), 20m13241. https:\/\/doi.org\/10.4088\/JCP.20m13241 (2020).","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"92311_CR19","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12954-022-00667-9","volume":"19","author":"K Chieh","year":"2022","unstructured":"Chieh, K., Patel, I., Walter, L. & Li, L. Disparities in Naloxone prescriptions in a university hospital during the COVID-19 pandemic. Harm Reduct. J. 19 (1), 84. https:\/\/doi.org\/10.1186\/s12954-022-00667-9 (2022).","journal-title":"Harm Reduct. J."},{"issue":"5","key":"92311_CR20","doi-asserted-by":"publisher","first-page":"e210393","DOI":"10.1001\/jamahealthforum.2021.0393","volume":"2","author":"AL O\u2019Donoghue","year":"2021","unstructured":"O\u2019Donoghue, A. L. et al. Trends in filled Naloxone prescriptions before and during the COVID-19 pandemic in the united States. JAMA Health Forum. 2 (5), e210393. https:\/\/doi.org\/10.1001\/jamahealthforum.2021.0393 (2021).","journal-title":"JAMA Health Forum"},{"key":"92311_CR21","doi-asserted-by":"publisher","first-page":"108548","DOI":"10.1016\/j.jsat.2021.108548","volume":"131","author":"SR Bailey","year":"2021","unstructured":"Bailey, S. R. et al. Associations of retention on buprenorphine for opioid use disorder with patient characteristics and models of care in the primary care setting. J. Subst. Abuse Treat. 131, 108548. https:\/\/doi.org\/10.1016\/j.jsat.2021.108548 (2021).","journal-title":"J. Subst. Abuse Treat."},{"issue":"0 1","key":"92311_CR22","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1360-0443.2012.04041.x","volume":"107","author":"MM Benningfield","year":"2012","unstructured":"Benningfield, M. M. et al. Opioid dependence during pregnancy: relationships of anxiety and depression symptoms to treatment outcomes. Addict. (Abingdon England). 107 (0 1), 74\u201382. https:\/\/doi.org\/10.1111\/j.1360-0443.2012.04041.x (2012). Suppl 1.","journal-title":"Addict. (Abingdon England)"},{"issue":"3","key":"92311_CR23","doi-asserted-by":"publisher","first-page":"21m14001","DOI":"10.4088\/JCP.21m14001","volume":"83","author":"K Zhang","year":"2022","unstructured":"Zhang, K. et al. Association between receipt of antidepressants and retention in buprenorphine treatment for opioid use disorder: a population-based retrospective cohort study. J. Clin. Psychiatry. 83 (3), 21m14001. https:\/\/doi.org\/10.4088\/JCP.21m14001 (2022).","journal-title":"J. Clin. Psychiatry"},{"key":"92311_CR24","doi-asserted-by":"publisher","first-page":"108244","DOI":"10.1016\/j.drugalcdep.2020.108244","volume":"216","author":"EL Friesen","year":"2020","unstructured":"Friesen, E. L. & Kurdyak, P. The impact of psychiatric comorbidity on treatment discontinuation among individuals receiving medications for opioid use disorder. Drug Alcohol Depend. 216, 108244. https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.108244 (2020).","journal-title":"Drug Alcohol Depend."},{"key":"92311_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jsat.2018.09.001","volume":"95","author":"H Samples","year":"2018","unstructured":"Samples, H., Williams, A. R., Olfson, M. & Crystal, S. Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of medicaid enrollees. J. Subst. Abuse Treat. 95, 9\u201317. https:\/\/doi.org\/10.1016\/j.jsat.2018.09.001 (2018).","journal-title":"J. Subst. Abuse Treat."},{"key":"92311_CR26","unstructured":"National institutes on drug abuse. Fentanyl drugfacts. Accessed 4 Dec 2023, from (2021a). https:\/\/nida.nih.gov\/publications\/drugfacts\/fentanyl"},{"issue":"5","key":"92311_CR27","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1067\/mem.2003.154","volume":"41","author":"GM Curran","year":"2003","unstructured":"Curran, G. M. et al. Emergency department use of persons with comorbid psychiatric and substance abuse disorders. Ann. Emerg. Med. 41 (5), 659\u2013667. https:\/\/doi.org\/10.1067\/mem.2003.154 (2003).","journal-title":"Ann. Emerg. Med."},{"key":"92311_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1471-227X-8-17","volume":"8","author":"GM Curran","year":"2008","unstructured":"Curran, G. M. et al. The association of psychiatric comorbidity and use of the emergency department among persons with substance use disorders: an observational cohort study. BMC Emerg. Med. 8, 17. https:\/\/doi.org\/10.1186\/1471-227X-8-17 (2008).","journal-title":"BMC Emerg. Med."},{"issue":"4","key":"92311_CR29","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","volume":"34","author":"D Ciccarone","year":"2021","unstructured":"Ciccarone, D. The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis. Curr. Opin. Psychiatry. 34 (4), 344\u2013350. https:\/\/doi.org\/10.1097\/YCO.0000000000000717 (2021).","journal-title":"Curr. Opin. Psychiatry"},{"key":"92311_CR30","doi-asserted-by":"publisher","first-page":"109310","DOI":"10.1016\/j.drugalcdep.2022.109310","volume":"232","author":"SC Warfield","year":"2022","unstructured":"Warfield, S. C. et al. Trends in comorbid opioid and stimulant use disorders among veterans receiving care from the veterans health administration, 2005\u20132019. Drug Alcohol Depend. 232, 109310. https:\/\/doi.org\/10.1016\/j.drugalcdep.2022.109310 (2022).","journal-title":"Drug Alcohol Depend."},{"key":"92311_CR31","unstructured":"National Institutes on drug abuse. Strengthening federal mental health and substance use disorder programs: opportunities, challenges, and emerging issues. Accessed 4 Oct 2023, from (2022)., March 23 https:\/\/nida.nih.gov\/about-nida\/legislative-activities\/testimony-to-congress\/2022\/strengthening-federal-mental-health-and-substance-use-disorder-programs-opportunities-challenges-and-emerging-issues"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92311-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92311-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92311-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T06:27:05Z","timestamp":1743661625000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92311-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,1]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["92311"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-92311-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4909624\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,1]]},"assertion":[{"value":"13 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11192"}}